But even accepting that, this was on the lower end of what is generally achieved.” For the study, Izumi and colleagues randomized 410 patients (mean age 73 years) who underwent mitral and/or aortic ...
The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...
The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...
The randomized, multi-center trial out of Japan randomized approximately 400 adults who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position to receive either ...
The ENBALV study provided the first large-scale evidence of the use of DOACs in patients who receive early anticoagulant therapy after bioprosthetic valve surgery. However, the evidence appears ...